Status:
UNKNOWN
Orthokine Therapy in Lumbar Degenerative Disease
Lead Sponsor:
Sutherland Medical Center
Conditions:
Degenerative Disc Disease
Lumbar Region
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The aim of the trial is the comparison of the effectiveness of two methods of Orthokine administration (periradicular or epidural) in lumbar degenerative disc disease.
Detailed Description
BACKGROUND: Lumbar Degenerative Disc Disease (LDDD) is a serious, global health problem for patients from the third decade of life. It is assumed that 75-85% of the population suffer from pain in the ...
Eligibility Criteria
Inclusion
- Clinical symptoms of LDDD in the lumbar region
- LDDD confirmed by MRI
- No contraindications to injections (hemorrhagic diathesis, anticoagulants, skin lesions)
- An adult consenting to participate in the study
Exclusion
- Presence of severe neurological deficits requiring surgery
- Discopathy of other origin - traumatic, spondylolisthesis, cancer, infection, inflammatory systemic diseases
- Previous surgical treatment in the lumbar spine
- Mental state that prevents cooperation during injection
- Contraindications for injection (hemorrhagic diathesis, anticoagulants, skin lesions)
- 5\. Lack of consent to participate in the study
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04734327
Start Date
February 1 2021
End Date
December 31 2022
Last Update
February 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sutherland Medical Center
Warsaw, Masovian Voivodeship, Poland, 04-036